title: Thymidylate synthase inhibitors.
authors.affiliation: Department of Medical Oncology, Newcastle Mater Misericordiae Hospital, Waratah, NSW, Australia. mdspa@alinga.newcastle.edu.au
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Ackland
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Clarke
authors.forename: Phillip
authors.initials: P
authors.lastname: Beale
authors.forename: Godefridus J
authors.initials: GJ
authors.lastname: Peters
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005472:Fluorouracil / Q000627:therapeutic use; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors*
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D005493:Folic Acid Antagonists; D013940:Thymidylate Synthase; D005472:Fluorouracil